Intrinsic Value

The intrinsic value of Clover Health Investments Corp (7QD) under the Base Case is 3.49 EUR per share. Compared with the current market price of 4.4 EUR, the stock appears Overvalued by 21% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

7QD Intrinsic Value
€3.49
Overvaluation 21%
Intrinsic Value
Price €4.4
Alert me when 7QD is below its intrinsic value
Today €2.79 · 36.6% below the current price

7QD is valued in line with its history. A premium of this size has been typical over the past 5 years.

Alternatives to 7QD

Fundamental Analysis

What Clover Health Investments Does

Health Care

Clover Health Investments Corp. is a U.S. health insurance company focused mainly on Medicare Advantage plans for older adults. It sells health coverage to Medicare beneficiaries, then gets paid through insurance premiums and government payments tied to the members it enrolls. Its core job is to help members get covered doctor visits, hospital care, prescription support, and other standard health benefits through its plans.

Headquarters
United States of America US
Employees
724
IPO date
Jun 12, 2020
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Clover Health Investments Corp

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

CLOV Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 7QD stock?

The intrinsic value for Clover Health Investments Corp (7QD) under the Base Case is 3.49 EUR.

Is 7QD stock undervalued or overvalued?

Compared with the current market price of 4.4 EUR, the stock appears Overvalued by 21% .

Back to Top